1. MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells
   Amir Sadra Zangouei et al, 2021, Genes and Environment CrossRef
2. Non-coding RNA in drug resistance of gastric cancer
   Ya-Jun Luo et al, 2019, World Journal of Gastrointestinal Oncology CrossRef
3. Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review)
   Chao Chen et al, 2019, International Journal of Oncology CrossRef
4. A predictive model for assessing prognostic risks in gastric cancer patients using gene expression and methylation data
   Dan Luo et al, 2021, BMC Medical Genomics CrossRef
5. Non-coding RNAs underlying chemoresistance in gastric cancer
   Arash Poursheikhani et al, 2020, Cellular Oncology CrossRef
6. 1,25D3 differentially suppresses bladder cancer cell migration and invasion through the induction of miR-101-3p
   Yingyu Ma et al, 2017, Oncotarget CrossRef
7. An in vitro study on the effects of the combination of salinomycin with cisplatin on human gastric cancer cells
   Zuwen Zhang et al, 2017, Molecular Medicine Reports CrossRef
8. Impact of MiRNAs and LncRNAs on Multidrug Resistance of Gastric Cancer
   Xiaoyan Yang et al, 2022, Combinatorial Chemistry & High Throughput Screening CrossRef
9. Role of non-coding RNAs as new therapeutic targets in regulating the EMT and apoptosis in metastatic gastric and colorectal cancers
   Nasim Ebrahimi et al, 2023, Cell Cycle CrossRef
10. Noncoding RNAs in gastric cancer: implications for drug resistance
    Ling Wei et al, 2020, Molecular Cancer CrossRef
11. Circular RNA circ_0026359 Enhances Cisplatin Resistance in Gastric Cancer via Targeting miR-1200/POLD4 Pathway
    Zongyao Zhang et al, 2020, BioMed Research International CrossRef
12. Liquiritin induces apoptosis and autophagy in cisplatin (DDP)-resistant gastric cancer cells in vitro and xenograft nude mice in vivo
    Feng Wei et al, 2017, International Journal of Oncology CrossRef
13. Genomic markers of resistance to targeted treatments in gastric cancer: potential new treatment strategies
    Alessandra Raimondi et al, 2018, Pharmacogenomics CrossRef
14. The role of miR-101 in esophageal and gastric cancer
    Athanasios Syllaios et al, 2021, Personalized Medicine CrossRef
15. Interactions between anticancer active platinum complexes and non-coding RNAs/microRNAs
    Bernhard Biersack, 2017, Non-coding RNA Research CrossRef
16. Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer
    Wanli Yang et al, 2017, Expert Opinion on Therapeutic Targets CrossRef
17. Targeting microRNA/UHRF1 pathways as a novel strategy for cancer therapy (Review)
    Hani Choudhry et al, 2017, Oncology Letters CrossRef
18. Non-coding RNAs in Various Stages of Liver Disease Leading to Hepatocellular Carcinoma: Differential Expression of miRNAs, piRNAs, lncRNAs, circRNAs, and sno/mt-RNAs
    Srinivas V. Koduru et al, 2018, Scientific Reports CrossRef
19. miR-4486 enhances cisplatin sensitivity of gastric cancer cells by restraining the JAK3/STAT3 signalling pathway
    Caijin Zhou et al, 2022, Journal of Chemotherapy CrossRef
20. DUSP2 regulates extracellular vesicle‐VEGF‐C secretion and pancreatic cancer early dissemination
    Chu‐An Wang et al, 2020, Journal of Extracellular Vesicles CrossRef